132 related articles for article (PubMed ID: 38309583)
1. GEC-ESTRO survey of
De Brabandere M; Placidi E; Siebert FA; Carlsson Tedgren Å; Slocker Escarpa A; Tagliaferri L; Andrássy M; Schulz C; Fog LS
Radiother Oncol; 2024 Apr; 193():110114. PubMed ID: 38309583
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
3. H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds.
Gonzalez-Perez V; Rembielak A; Guinot JL; Jaberi R; Lancellotta V; Walter R; Zuchora A; Budrukkar A; Kovács G; Jürgenliemk-Schulz I; Siebert FA; Tagliaferri L
Radiother Oncol; 2022 Oct; 175():122-132. PubMed ID: 36030932
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
5. Transitioning from a COMS-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: A single institutional experience.
Meltsner SG; Rodrigues A; Materin MA; Kirsch DG; Craciunescu O
J Appl Clin Med Phys; 2023 May; 24(5):e13902. PubMed ID: 36637797
[TBL] [Abstract][Full Text] [Related]
6. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
7. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
8. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
Kovács G; Martinez-Monge R; Budrukkar A; Guinot JL; Johansson B; Strnad V; Skowronek J; Rovirosa A; Siebert FA;
Radiother Oncol; 2017 Feb; 122(2):248-254. PubMed ID: 27889184
[TBL] [Abstract][Full Text] [Related]
9. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level.
Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; DeWerd LA; Papagiannis P; Rivard MJ; Siebert FA; Vijande J
Radiother Oncol; 2022 Nov; 176():108-117. PubMed ID: 36167195
[TBL] [Abstract][Full Text] [Related]
10. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
11. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
12. An improved treatment planning and quality assurance process for Collaborative Ocular Melanoma Study eye plaque brachytherapy.
Weersink RA; Patterson S; Ballantyne H; Di Tomasso A; Borg J; Vitkin A; Rink A; Beiki-Ardakani A
Brachytherapy; 2019; 18(5):658-667. PubMed ID: 31235445
[TBL] [Abstract][Full Text] [Related]
13. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
14. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
15. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
16. Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk.
Itta F; Liuzzi R; Farella A; Porri G; Pacelli R; Conson M; Oliviero C; Buonanno F; Breve MA; Cennamo G; Clemente S; Cella L
Phys Med; 2020 Aug; 76():285-293. PubMed ID: 32738776
[TBL] [Abstract][Full Text] [Related]
17. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.
Kirisits C; Rivard MJ; Baltas D; Ballester F; De Brabandere M; van der Laarse R; Niatsetski Y; Papagiannis P; Hellebust TP; Perez-Calatayud J; Tanderup K; Venselaar JL; Siebert FA
Radiother Oncol; 2014 Jan; 110(1):199-212. PubMed ID: 24299968
[TBL] [Abstract][Full Text] [Related]
18. A snapshot of medical physics practice patterns.
Kisling KD; Ger RB; Netherton TJ; Cardenas CE; Owens CA; Anderson BM; Lee J; Rhee DJ; Edward SS; Gay SS; He Y; David SD; Yang J; Nitsch PL; Balter PA; Urbauer DL; Peterson CB; Court LE; Dube S
J Appl Clin Med Phys; 2018 Nov; 19(6):306-315. PubMed ID: 30272385
[TBL] [Abstract][Full Text] [Related]
19. Treatment plan optimization and robustness of
Heilemann G; Fetty L; Dulovits M; Blaickner M; Nesvacil N; Georg D; Dunavoelgyi R
Radiother Oncol; 2017 Apr; 123(1):119-124. PubMed ID: 28185660
[TBL] [Abstract][Full Text] [Related]
20. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
Bard JJ
Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
